Features and outcomes of secondary sepsis and urinary tract infections in COVID-19 patients treated with stem cell nebulization

Gina M. Torres Zambrano, Rene Antonio Rivero, Carlos A. Villegas Valverde, Yendry Ventura Carmenate
doi: https://doi.org/10.1101/2020.12.05.20244483

Article Information

doi 
https://doi.org/10.1101/2020.12.05.20244483
History 
  • December 7, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Gina M. Torres Zambrano1,*,
  2. Rene Antonio Rivero2,
  3. Carlos A. Villegas Valverde3 and
  4. Yendry Ventura Carmenate4
  1. 1Conception and design, acquisition of data. Consultant Urologist at Abu Dhabi Stem Cell Center (ADSCC). Telephone number: +971 506439223. dr.torresz{at}gmail.com; gina.zambrano{at}adscc.ae.
  2. 2Head of ADSCC Scientific Committee. rene.rivero{at}adscc.ae
  3. 3Analysis and interpretation of data, statistical analysis. Researcher at the ADSCC Immunology Laboratory. carlos.valverde{at}adscc.ae
  4. 4ADSCC General Manager. yendry.ventura{at}adscc.ae
  1. ↵*Corresponding author; email: dr.torresz{at}gmail.com
Back to top
Posted December 07, 2020.
Download PDF
Data/Code
Email
Features and outcomes of secondary sepsis and urinary tract infections in COVID-19 patients treated with stem cell nebulization
Gina M. Torres Zambrano, Rene Antonio Rivero, Carlos A. Villegas Valverde, Yendry Ventura Carmenate
medRxiv 2020.12.05.20244483; doi: https://doi.org/10.1101/2020.12.05.20244483
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area